source
- Legend Biotech appoints former Novartis exec Ingrid Zhang as CEO amid falling share priceLegend Biotech announced the appointment of Ingrid Zhang, a former Novartis executive, as its new chief executive officer. The leadership change comes as the company faces growing competition for…
- Biopharma prediction markets raise insider-info concerns, regulators weigh oversightPrediction markets are emerging as platforms where participants can wager on biopharma events such as clinical trial results and FDA approvals. The format allows crowds to aggregate expectations ab…